Grazax clinical trials
How each study uses Grazax is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Grazax
- 8
Studies by the year they started
9 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 2
ALK-Abelló A/S (7) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Imperial College London (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Grazax is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Grass Pollen Immunotherapy Plus Dupilumab for Tolerance InductionCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT04502966Written as Grazax®
- Tolerability of Grazax in Patients With Hayfever in Real Life SettingsCompletedPhase 4ALK-Abelló A/SNCT01433510Written as Grazax
- Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course StudyCompletedPhase 2Imperial College LondonNCT02005627Written as Grazax
- Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®CompletedPhase 4ALK-Abelló A/SNCT02437786Written as GRAZAX
- Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral LyophilisateCompletedPhase 4ALK-Abelló A/SNCT01854736Written as Grazax
- Grazax Asthma PreventionCompletedPhase 3ALK-Abelló A/SNCT01061203Written as Grazax
- A Trial of Grazax in Subjects With HayfeverCompletedPhase 3ALK-Abelló A/SNCT00421655Written as Grazax
- A Trial Evaluating Tolerability of Grazax Treatment in Combination With AntihistamineCompletedPhase 3ALK-Abelló A/SNCT01740284Written as Grazax + Aerius
- A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax TreatmentCompletedPhase 3ALK-Abelló A/SNCT00773240Written as Grazax